-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Rfhi3DbxPYYthCuQGzVlcTA8txzpru3yj9y3cZW5AC+Ss22VNsZ8GCEqmVNTu4+2 yyYnRxKyKKwXlm6UAf/w0g== 0000950117-98-000277.txt : 19980218 0000950117-98-000277.hdr.sgml : 19980218 ACCESSION NUMBER: 0000950117-98-000277 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980217 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALGOS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000924862 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223142274 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-48097 FILM NUMBER: 98541508 BUSINESS ADDRESS: STREET 1: 4900 ROUTE 33 CITY: NEPTUNE STATE: NJ ZIP: 07753 BUSINESS PHONE: 9089385959 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LYLE KAREN CENTRAL INDEX KEY: 0001034590 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ALGOS PHARMACEUTICAL CORP CITY: COLLINGWOOD PLAZA STATE: NJ ZIP: 07753-6804 BUSINESS PHONE: 9089385959 MAIL ADDRESS: STREET 1: ALGOS PHARMACEUTICAL CORP STREET 2: COLLLINGWOOD PLAZA, 4900 ROUTE 33 CITY: NEPTUNE STATE: NJ ZIP: 07753-6804 SC 13G 1 KAREN LYLE SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13D-102) INFORMATION STATEMENT PURSUANT TO RULES 13D-1 AND 13D-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 ALGOS PHARMACEUTICAL CORPORATION (NAME OF ISSUER) COMMON STOCK, PAR VALUE $.01 PER SHARE (TITLE OF CLASS OF SECURITIES) 015869 10 0 (CUSIP NUMBER) Page 1 of 5 pages 13G CUSIP NO. 015869 10 0 ----------- 1. NAME OF REPORTING PERSON: KAREN LYLE ------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) [ ] (B) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION: UNITED STATES CITIZEN ------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER: 1,742,654 ------------------------------------------------------------- 6. SHARED VOTING POWER: -0- ------------------------------------------------------------- 7. SOLE DISPOSITIVE POWER: 1,742,654 ------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER: -0- ------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 1,742,654 ------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES: [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9: 10.9% ------------------------------------------------------------- 12. TYPE OF REPORTING PERSON: IN ------------------------------------------------------------- Page 2 of 5 pages Item 1. (a) Name of Issuer: Algos Pharmaceutical Corporation (b) Address of Issuer's Principal Executive Offices: Collingwood Plaza, 4900 Route 33 Neptune, New Jersey 07753-6804 Item 2. (a) Name of Person Filing: Karen Lyle (b) Address of Principal Business Office: Algos Pharmaceutical Corporation Collingwood Plaza, 4900 Route 33 Neptune, New Jersey 07753-6804 (c) Citizenship: United States (d) Title of Class of Securities: Common Stock, $.01 par value (e) CUSIP Number: 015869 10 0 Item 3. Not applicable. Item 4. Ownership (a) Amount Beneficially Owned: 1,742,654 (b) Percent of Class: 10.9% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 1,742,654 -------------------------------------------- (ii) shared power to vote or to direct the vote: -0- -------------------------------------------- (iii) sole power to dispose or to direct the disposition of: 1,742,654 ------------------------------------------- (iv) shared power to dispose or to direct the disposition of: -0- ------------------------------------------- Page 3 of 5 pages Item 5. Ownership of Five Percent or Less of a Class: Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person: The 1,742,654 shares reported by Mrs. Lyle, includes 74,700 shares of common stock and options to purchase 300,500 shares owned directly by John Lyle, husband of Mrs. Lyle, and 38 shares owned directly by Mrs. Lyle's son, as to which Mrs. Lyle disclaims beneficial ownership. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: Not applicable. Item 8. Identification and Classification of Members of the Group: Not applicable. Item 9. Notice of Dissolution of Group: Not applicable. Item 10. Certification: Not applicable. Page 4 of 5 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 1998 /s/ Karen Lyle ------------------------------ Karen Lyle Page 5 of 5 pages -----END PRIVACY-ENHANCED MESSAGE-----